PCN292 - CANCER DRUGS IN GERMANY- HTA DECISIONS OF NEW AND INNOVATIVE ONCOLOGY DRUGS IN GERMANY – AN ANALYSIS USING THE PRISMACCESS® DATABASE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.374
https://www.valueinhealthjournal.com/article/S1098-3015(18)33674-X/fulltext
Title :
PCN292 - CANCER DRUGS IN GERMANY- HTA DECISIONS OF NEW AND INNOVATIVE ONCOLOGY DRUGS IN GERMANY – AN ANALYSIS USING THE PRISMACCESS® DATABASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33674-X&doi=10.1016/j.jval.2018.09.374
First page :
Section Title :
Open access? :
No
Section Order :
2275